Aberrant crypt foci: Endoscopic assessment and cell kinetics characterization

International Journal of Colorectal Disease

Volumn 24, Issue 4, 2009, Pages 441-450

  Figueiredo, Pedro ^a   Donato, Maria ^b   Urbano, Marta ^b   Goulão, Helena ^b   Gouveia, Hermano ^a   Sofia, Carlos ^a   Leitão, Maximino ^a   Freitas, Diniz ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Aberrant crypt foci; Cell kinetics; Chromoscopy; Colonoscopy; Colorectal cancer; Magnification

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CELL KINETICS; CELL PROLIFERATION; COLON POLYP; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL DISEASE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CRYPT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL PROLIFERATION; COLON; COLONIC POLYPS; DEMOGRAPHY; ENDOSCOPY; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED;

EID: 61549087841     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0576-z     Document Type: Article

References (52)

1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108
2. Rex DK, Johnson DA, Lieberman DA et al (2000) Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 95:868-877
3. Vogelstein B, Fearon ER, Hamilton SR et al (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532
4. Bostick RM, Fosdick L, Grandits GA et al (1997) Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients. Cancer Epidemiol Biomarkers Prev 6:1011-1019
5. Roncucci L, Scalmati A, Ponz de Leon M (1991) Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel. Cancer 68:873-878
6. Sandler RS, Baron JA, Tosteson TD et al (2000) Rectal mucosal proliferation and risk of colorectal adenomas: Results from a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 9:653-656
7. Scalmati A, Roncucci L, Ghidini G et al (1990) Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel. Cancer Res 50:7937-7941
8. Freitas D, Goulão MH, Camacho E et al (2002) Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: A prospective study. Hepatogastroenterology 49:1269-1274
9. Anti M, Armuzzi A, Morini S et al (2001) Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas. Gut 48:238-246
10. Martin C, Connelly A, Keku TO et al (2002) Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas. Gastroenterology 123:1770-1777
11. Bernstein C, Bernstein H, Garewal H et al (1999) A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res 59:2353-2357
12. Bird RP (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett 37:147-151
13. Boivin GP, Washington K, Yang K et al (2003) Pathology of mouse models of intestinal cancer: Consensus report and recommendations. Gastroenterology 124:762-777
14. Bird RP, McLellan EA, Bruce WR (1989) Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv 8:189-200
15. McLellan EA, Medline A, Bird RP (1991) Dose response and proliferative characteristics of aberrant crypt foci: Putative preneoplastic lesions in rat colon. Carcinogenesis 12:2093-2098
16. Mereto E, Frencia L, Ghia M (1994) Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine. Cancer Lett 76:5-9
17. Shpitz B, Bomstein Y, Kariv N et al (1998) Chemopreventive effect of aspirin on growth of aberrant crypt foci in rats. Int J Colorectal Dis 13:169-172
18. Wargovich MJ, Chen CD, Harris C et al (1995) Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. Int J Cancer 60:515-519
19. Adler DG, Gostout CJ, Sorbi D et al (2002) Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc 56:657-662
20. Hurlstone DP, Karajeh M, Sanders DS et al (2005) Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia. Am J Gastroenterol 100:1283-1289
21. Moxon D, Raza M, Kenney R et al (2005) Relationship of aging and tobacco use with the development of aberrant crypt foci in a predominantly African-American population. Clin Gastroenterol Hepatol 3:271-278
22. Rudolph RE, Dominitz JA, Lampe JW et al (2005) Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidemiol Biomarkers Prev 14:605-608
23. Takayama T, Katsuki S, Takahashi Y et al (1998) Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339:1277-1284
24. Yokota T, Sugano K, Kondo H et al (1997) Detection of aberrant crypt foci by magnifying colonoscopy. Gastrointest Endosc 46:61-65 Jul
25. Seike K, Koda K, Oda K et al (2006) Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value goes colonic advanced neoplasms. Am J Gastroenterol 101:1362-1369
26. Stevens RG, Swede H, Heinen CD et al (2007) Aberrant crypt foci in patients with the positive family history of sporadic colorectal cancer. Cancer Lett 248:262-268
27. Konstantakos AK, Siu IM, Pretlow TG et al (1996) Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer. Gastroenterology 111:772-777
28. Otori K, Konishi M, Sugiyama K et al (1998) Infrequent somatic mutation of the adenomatous polyposis coli gene in aberrant crypt foci of human colon tissue. Cancer 83:896-900
29. Takayama T, Ohi M, Hayashi T et al (2001) Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 121:599-611
30. Pedroni M, Sala E, Scarselli A et al (2001) Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res 61:896-899
31. Winawer S, Fletcher R, Rex D et al (2003) Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124:544-560
32. Bagnardi V, Blangiardo M, La Vecchia C et al (2001) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85:1700-1705
33. Cho E, Smith-Warner SA, Ritz J et al (2004) Alcohol intake and colorectal cancer: A pooled analysis of 8 cohort studies. Ann Intern Med 140:603-613
34. Giovannucci E (2001) An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 10:725-731
35. Bond JH (2000) Polyp guideline: Diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 95:3053-3063
36. Lieberman DA, Weiss DG, Bond JH et al (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343:162-168
37. Anderson JC, Alpern Z, Sethi G et al (2005) Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population. Am J Gastroenterol 100:2049-2055
38. Bongaerts BW, of Goeij AF, of Vogel S et al (2007) Alcohol consumption and distinct molecular pathways to colorectal cancer. Br J Nutr 97:430-434
39. Gondal G, Grotmol T, Hofstad B et al (2005) Lifestyle-related risk factors and chemoprevention for colorectal neoplasia: Experience from the large-scale NORCCAP screening trial. Eur J Cancer Prev 14:373-379
40. Nucci MR, Robinson CR, Longo P et al (1997) Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol 28:1396-1407
41. Roncucci L, Modica S, Pedroni M et al (1998) Aberrant crypt foci in patients with colorectal cancer. Br J Cancer 77:2343-2348
42. Takayama T, Ohi M, Hayashi T et al (2001) Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 121:599-611
43. Jothy S, Slesak B, Harłozińska A et al (1996) Field effect of human colon carcinoma on normal mucosa: Relevance of carcinoembryonic antigen expression. Tumour Biol 17:58-64
44. Braakhuis BJ, Tabor MP, Kummer JA et al (2003) A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res 63:1727-1730
45. Siu IM, Robinson DR, Schwartz S et al (1999) The identification of monoclonality in human aberrant crypt foci. Cancer Res 59:63-66
46. Shpitz B, Bomstein Y, Mekori Y et al (1997) Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon. Am J Surg 174:425-430
47. Nobuoka A, Takayama T, Miyanishi K et al (2004) Glutathione-S-transferase P1-1 protects aberrant crypt foci from apoptosis induced by deoxycholic acid. Gastroenterology 127:428-443
48. Shpitz B, Bomstein Y, Mekori Y et al (1997) Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon. Am J Surg 174:425-430
49. Aotake T, Lu CD, Chiba Y et al (1999) Changes of angiogenesis and tumor cell apoptosis during colorectal carcinogenesis. Clin Cancer Res 5:135-142
50. Tsujitani S, Shirai H, Tatebe S et al (1996) Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma. Cancer 77:1711-1716
51. Hao X, Du M, Bishop AE et al (1998) Imbalance between proliferation and apoptosis in the development of colorectal carcinoma. Virchows Arch 433:523-527
52. Koornstra JJ, de Jong S, Hollema H et al (2003) Changes in apoptosis during the development of colorectal cancer: A systematic review of the literature. Crit Rev Oncol Hematol 45:37-53